Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 02:14:10 UTC |
---|
Update Date | 2021-09-26 22:59:16 UTC |
---|
HMDB ID | HMDB0248788 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid |
---|
Description | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid belongs to the class of organic compounds known as pyrazinecarboxamides. Pyrazinecarboxamides are compounds containing a pyrazine ring which bears a carboxamide. Based on a literature review very few articles have been published on {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). {4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC1=NC(C)=C(N=C1C(N)=O)C1=CC=C(C=C1)C1CCC(CC(O)=O)CC1 InChI=1S/C21H25N3O3/c1-12-19(24-20(21(22)27)13(2)23-12)17-9-7-16(8-10-17)15-5-3-14(4-6-15)11-18(25)26/h7-10,14-15H,3-6,11H2,1-2H3,(H2,22,27)(H,25,26) |
---|
Synonyms | Value | Source |
---|
{4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetate | Generator |
|
---|
Chemical Formula | C21H25N3O3 |
---|
Average Molecular Weight | 367.449 |
---|
Monoisotopic Molecular Weight | 367.189591677 |
---|
IUPAC Name | 2-{4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid |
---|
Traditional Name | {4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1=NC(C)=C(N=C1C(N)=O)C1=CC=C(C=C1)C1CCC(CC(O)=O)CC1 |
---|
InChI Identifier | InChI=1S/C21H25N3O3/c1-12-19(24-20(21(22)27)13(2)23-12)17-9-7-16(8-10-17)15-5-3-14(4-6-15)11-18(25)26/h7-10,14-15H,3-6,11H2,1-2H3,(H2,22,27)(H,25,26) |
---|
InChI Key | YXFNPRHZMOGREC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrazinecarboxamides. Pyrazinecarboxamides are compounds containing a pyrazine ring which bears a carboxamide. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazines |
---|
Sub Class | Pyrazines |
---|
Direct Parent | Pyrazinecarboxamides |
---|
Alternative Parents | |
---|
Substituents | - Pyrazinecarboxamide
- 2-heteroaryl carboxamide
- Monocyclic benzene moiety
- Benzenoid
- Heteroaromatic compound
- Carboxamide group
- Primary carboxylic acid amide
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Azacycle
- Organic oxide
- Organic oxygen compound
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
{4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C | 3397.8 | Semi standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C | 3212.4 | Standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C | 4192.5 | Standard polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 3563.7 | Semi standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 3399.9 | Standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 4256.1 | Standard polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 3476.3 | Semi standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 3403.8 | Standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 3941.3 | Standard polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C(C)(C)C | 3811.2 | Semi standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C(C)(C)C | 3645.1 | Standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C(C)(C)C | 4295.3 | Standard polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3996.0 | Semi standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3773.0 | Standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4300.4 | Standard polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4029.1 | Semi standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3958.3 | Standard non polar | 33892256 | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4087.7 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-066s-1197000000-7172125dc11bdf65b20e | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 10V, Positive-QTOF | splash10-0gb9-0009000000-3feddcd76d79b3765cb4 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 20V, Positive-QTOF | splash10-0udi-0049000000-d281229b72c47b74925d | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 40V, Positive-QTOF | splash10-0pxr-0094000000-1392fae5889379dd174d | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 10V, Negative-QTOF | splash10-014i-0009000000-19efc1e763672b76b04e | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 20V, Negative-QTOF | splash10-0096-6039000000-0465d331e0e7901219ae | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 40V, Negative-QTOF | splash10-0006-9074000000-fac3feccd5fe60c02a55 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|